Original Research
13 August 2019

General and Abdominal Adiposity and Mortality in Mexico City: A Prospective Study of 150 000 Adults

Publication: Annals of Internal Medicine
Volume 171, Number 6
Visual Abstract. Adiposity and Mortality in Mexico City Conflicting evidence exists as to whether overweight and obesity are associated with mortality among Hispanic populations. This study followed more than 150 000 adults aged 35 to 89 years in Mexico City for up to 14 years to examine the relationship between 3 measures of adiposity (body mass index, waist circumference, and waist-to-hip-ratio) and mortality.
Visual Abstract. Adiposity and Mortality in Mexico City
Conflicting evidence exists as to whether overweight and obesity are associated with mortality among Hispanic populations. This study followed more than 150 000 adults aged 35 to 89 years in Mexico City for up to 14 years to examine the relationship between 3 measures of adiposity (body mass index, waist circumference, and waist-to-hip-ratio) and mortality.

Abstract

Background:

Some reports suggest that body mass index (BMI) is not strongly associated with mortality in Hispanic populations.

Objective:

To assess the causal relevance of adiposity to mortality in Mexican adults, avoiding reverse causality biases.

Design:

Prospective study.

Setting:

2 Mexico City districts.

Participants:

159 755 adults aged 35 years and older at recruitment, followed for up to 14 years. Participants with a hemoglobin A1c level of 7% or greater, diabetes, or other chronic diseases were excluded.

Measurements:

BMI, waist-to-hip ratio, waist circumference, and cause-specific mortality. Cox regression, adjusted for confounders, yielded mortality hazard ratios (HRs) after at least 5 years of follow-up and before age 75 years.

Results:

Among 115 400 participants aged 35 to <75 years at recruitment, mean BMI was 28.0 kg/m2 (SD, 4.1 kg/m2) in men and 29.6 kg/m2 (SD, 5.1 kg/m2) in women. The association of BMI at recruitment with all-cause mortality was J-shaped, with the minimum at 25 to <27.5 kg/m2. Above 25 kg/m2, each 5-kg/m2 increase in BMI was associated with a 30% increase in all-cause mortality (HR, 1.30 [95% CI, 1.24 to 1.36]). This association was stronger at ages 40 to <60 years (HR, 1.40 [CI, 1.30 to 1.49]) than at ages 60 to <75 years (HR, 1.24 [CI, 1.17 to 1.31]) but was not materially affected by sex, smoking, or other confounders. The associations of mortality with BMI and waist-to-hip ratio were similarly strong, and each was weakened only slightly by adjustment for the other. Waist circumference was strongly related to mortality and remained so even after adjustment for BMI and hip circumference.

Limitation:

Analyses were limited to mortality.

Conclusion:

General, and particularly abdominal, adiposity were strongly associated with mortality in this Mexican population.

Primary Funding Source:

Mexican Health Ministry, Mexican National Council of Science and Technology, Wellcome Trust, Medical Research Council, and Kidney Research UK.

Get full access to this article

View all available purchase options and get full access to this article.

Supplemental Material

Supplement. Supplementary Material

References

1.
GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1345-1422. [PMID: 28919119]  doi: 10.1016/S0140-6736(17)32366-8
2.
Afshin AForouzanfar MHReitsma MBet alGBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377:13-27. [PMID: 28604169]  doi: 10.1056/NEJMoa1614362
3.
Global BMI Mortality CollaborationDiAngelantonio EBhupathiraju ShNet al. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet. 2016;388:776-86. [PMID: 27423262]  doi: 10.1016/S0140-6736(16)30175-1
4.
Heymsfield SBPeterson CMThomas DMet al. Why are there race/ethnic differences in adult body mass index-adiposity relationships? A quantitative critical review. Obes Rev. 2016;17:262-75. [PMID: 26663309]  doi: 10.1111/obr.12358
5.
Zheng WMcLerran DFRolland Bet al. Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med. 2011;364:719-29. [PMID: 21345101]  doi: 10.1056/NEJMoa1010679
6.
Gajalakshmi VLacey BKanimozhi Vet al. Body-mass index, blood pressure, and cause-specific mortality in India: a prospective cohort study of 500–810 adults. Lancet Glob Health. 2018;6:e787-e794. [PMID: 29903379]  doi: 10.1016/S2214-109X(18)30267-5
7.
Fontaine KRMcCubrey RMehta Tet al. Body mass index and mortality rate among Hispanic adults: a pooled analysis of multiple epidemiologic data sets. Int J Obes (Lond). 2012;36:1121-6. [PMID: 21986709]  doi: 10.1038/ijo.2011.194
8.
Mehta TMcCubrey RPajewski NMet al. Does obesity associate with mortality among Hispanic persons? Results from the National Health Interview Survey. Obesity (Silver Spring). 2013;21:1474-7. [PMID: 23596157]  doi: 10.1002/oby.20105
9.
Tapia-Conyer RKuri-Morales PAlegre-Díaz Jet al. Cohort profile: the Mexico City Prospective Study. Int J Epidemiol. 2006;35:243-9. [PMID: 16556648]
10.
Youngman LDClark SManley Set al. Reliable measurement of glycated hemoglobin in frozen blood samples: implications for epidemiologic studies [Letter]. Clin Chem. 2002;48:1627-9. [PMID: 12194959]
11.
Mathers CDFat DMInoue Met al. Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ. 2005;83:171-7. [PMID: 15798840]
12.
International Statistical Classification of Diseases and Related Health Problems, 10th Revision. vol 2. Geneva: World Health Organization; 2004.
13.
Alegre-Díaz JHerrington WLópez-Cervantes Met al. Diabetes and cause-specific mortality in Mexico City. N Engl J Med. 2016;375:1961-1971. [PMID: 27959614]  doi: 10.1056/NEJMoa1605368
14.
Plummer M. Improved estimates of floating absolute risk. Stat Med. 2004;23:93-104. [PMID: 14695642]
15.
Pischon TBoeing HHoffmann Ket al. General and abdominal adiposity and risk of death in Europe. N Engl J Med. 2008;359:2105-20. [PMID: 19005195]  doi: 10.1056/NEJMoa0801891
16.
Flores-Hernández SSaturno-Hernández PJReyes-Morales Het al. Quality of diabetes care: the challenges of an increasing epidemic in Mexico. Results from two national health surveys (2006 and 2012). PLoS One. 2015;10:e0133958. [PMID: 26230991]  doi: 10.1371/journal.pone.0133958
17.
Wormser DKaptoge SDiAngelantonio Eet alEmerging Risk Factors Collaboration. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet. 2011;377:1085-95. [PMID: 21397319]  doi: 10.1016/S0140-6736(11)60105-0
18.
Whitlock GLewington SSherliker Pet alProspective Studies Collaboration. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373:1083-96. [PMID: 19299006]  doi: 10.1016/S0140-6736(09)60318-4
19.
Sun YLiu BSnetselaar LGet al. Association of normal-weight central obesity with all-cause and cause-specific mortality among postmenopausal US women. JAMA Network Open. 2019; doi:10.

Comments

0 Comments
Sign In to Submit A Comment
Dalton Tidwell, Mark Dame, Alan N. Peiris 20 August 2019
Regarding General and Abdominal Adiposity and Mortality in Mexico City
Dear Dr. Laine,
We read with interest and nostalgia the paper by Gnatiuc et al (1) that reported a link between abdominal adiposity and mortality in Mexicans. We reported an enhanced cardiovascular risk profile linked to visceral fat estimated by computerized tomography in this journal in 1989 (2). The enhanced morbidity and mortality linked to abdominal obesity, however, dates back several decades to Jean Vague, a French physician. There is little doubt that abdominal adiposity with its increased visceral fat and frequent steatosis identifies individuals of both genders at very high risk of metabolic and cardiovascular complications including early death. Even individuals of near normal weight with increased abdominal adiposity may be at such risk. Studies have confirmed this association across many different cultures and countries. Abdominal obesity has reached pandemic proportions. In order to address this pressing public health issue and to contain soaring costs it behooves researchers to consider the pathogenesis of abdominal adiposity.
Further, we would like to submit the following evolutionary hypothesis for the development of abdominal adiposity. A high carbohydrate diet is experienced in Asian and Hispanic cultures. As well, an increase in refined carbohydrate intake has extended to all cultures in the last few decades. This increase has been documented by the Centers for Disease control (CDC) and independent entities such as PEW research. Physicians have warned about the dangers of a high fat diet but largely ignored the potential dangers of the excessive intake of refined carbohydrates. The PURE study, a global initiative confirmed that high carbohydrate intake was linked closely to mortality, and a high fat intake had an inverse relationship to mortality (3). When low calorie diets are compared in obese diabetic patients – a low carbohydrate diet is clearly superior to a high carbohydrate diet in improving metabolic parameters and reducing visceral fat (4). Moreover, satiety may be better induced on a low carbohydrate diet than a low-fat diet. We do not discount that a plant based high carbohydrate low fat diet may also have metabolic benefits. However, since a reduction in vascular endothelial dysfunction in obesity is related to a reduction in visceral adiposity (5) additional studies addressing the benefits of a low refined carbohydrate diet are urgently needed. It is possible that physicians need a paradigm shift from the dangers of a high fat diet to the dangers of a processed-food carbohydrate diet. We look forward to the authors’ response.

References:
(1) Gnatiuc L, Alegre-Díaz J, Wade R, et al. General and Abdominal Adiposity and Mortality in Mexico City: Prospective Study of 150 000 Adults. Ann Intern Med. [Epub ahead of print 13 August 2019] doi: 10.7326/M18-3502

(2) Peiris AN, Sothmann MS, Hoffmann RG, et al. Adiposity, fat distribution, and cardiovascular risk. Ann Intern Med. 1989 Jun 1;110(11):867-72

(3) Dehghan M, Mente A, Zhang X, et al. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study. Lancet. 2017 Nov 4;390(10107):2050-2062. doi: 10.1016/S0140-6736(17)32252-3.

(4) Miyashita Y, Koide N, Ohtsuka M, et al. Beneficial effect of low carbohydrate in low calorie diets on visceral fat reduction in type 2 diabetic patients with obesity. Diabetes Res Clin Pract. 2004 Sep;65(3):235-41.

(5) Park SH, Shim KW. Reduction in Visceral Adiposity is Highly Related to Improvement in Vascular Endothelial Dysfunction among Obese Women: An Assessment of Endothelial Function by Radial Artery Pulse Wave Analysis. Yonsei Med J. 2005 Aug 31; 46(4): 511–518. doi: 10.3349/ymj.2005.46.4.511.

Information & Authors

Information

Published In

cover image Annals of Internal Medicine
Annals of Internal Medicine
Volume 171Number 617 September 2019
Pages: 397 - 405

History

Published online: 13 August 2019
Published in issue: 17 September 2019

Keywords

Authors

Affiliations

Louisa Gnatiuc, MSc
University of Oxford, Oxford, United Kingdom (L.G., R.W., R.C., R.C., W.G.H., M.H., S.L., R.P., J.R.E.)
Jesus Alegre-Díaz, MD
National Autonomous University of Mexico, Mexico City, Mexico (J.A., R.R., R.T., A.G., C.G., M.S., P.K.)
Rachel Wade, MSc
University of Oxford, Oxford, United Kingdom (L.G., R.W., R.C., R.C., W.G.H., M.H., S.L., R.P., J.R.E.)
Raúl Ramirez-Reyes
National Autonomous University of Mexico, Mexico City, Mexico (J.A., R.R., R.T., A.G., C.G., M.S., P.K.)
Roberto Tapia-Conyer, PhD
National Autonomous University of Mexico, Mexico City, Mexico (J.A., R.R., R.T., A.G., C.G., M.S., P.K.)
Adrián Garcilazo-Ávila, MSc
National Autonomous University of Mexico, Mexico City, Mexico (J.A., R.R., R.T., A.G., C.G., M.S., P.K.)
Erwin Chiquete, MD
Salvador Zubirán National Institute of Medical Sciences and Nutrition, Mexico City, Mexico (E.C.)
Carlos Gonzáles-Carballo, MSc
National Autonomous University of Mexico, Mexico City, Mexico (J.A., R.R., R.T., A.G., C.G., M.S., P.K.)
Martha Solano-Sanchez, MSc
National Autonomous University of Mexico, Mexico City, Mexico (J.A., R.R., R.T., A.G., C.G., M.S., P.K.)
Robert Clarke, MD
University of Oxford, Oxford, United Kingdom (L.G., R.W., R.C., R.C., W.G.H., M.H., S.L., R.P., J.R.E.)
Rory Collins, FRS
University of Oxford, Oxford, United Kingdom (L.G., R.W., R.C., R.C., W.G.H., M.H., S.L., R.P., J.R.E.)
William G. Herrington, MD
University of Oxford, Oxford, United Kingdom (L.G., R.W., R.C., R.C., W.G.H., M.H., S.L., R.P., J.R.E.)
Michael Hill, PhD
University of Oxford, Oxford, United Kingdom (L.G., R.W., R.C., R.C., W.G.H., M.H., S.L., R.P., J.R.E.)
Sarah Lewington, DPhil
University of Oxford, Oxford, United Kingdom (L.G., R.W., R.C., R.C., W.G.H., M.H., S.L., R.P., J.R.E.)
Richard Peto, FRS
University of Oxford, Oxford, United Kingdom (L.G., R.W., R.C., R.C., W.G.H., M.H., S.L., R.P., J.R.E.)
Jonathan R. Emberson, PhD
University of Oxford, Oxford, United Kingdom (L.G., R.W., R.C., R.C., W.G.H., M.H., S.L., R.P., J.R.E.)
Pablo Kuri-Morales, MD
National Autonomous University of Mexico, Mexico City, Mexico (J.A., R.R., R.T., A.G., C.G., M.S., P.K.)
Note: Ms. Gnatiuc, Ms. Wade, and Dr. Emberson had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the analysis.
Financial Support: This study was supported by grants from the Wellcome Trust (058299/Z/99, 090532, 098381), Mexican Health Ministry, National Council of Science and Technology for Mexico, Cancer Research UK, British Heart Foundation, and United Kingdom Medical Research Council (MRC-UK). Dr. Herrington is funded by an MRC-UK–Kidney Research UK Professor David Kerr Clinician Scientist Award.
Disclosures: Ms. Wade reports grants from the MRC during the conduct of the study. Dr. Collins reports grants from the MRC, British Heart Foundation, Cancer Research UK, Wellcome Trust, The Medicines Company, Pfizer, and Merck outside the submitted work. Dr. Herrington reports grants from MRC-UK and Kidney Research UK during the conduct of the study, and grants from Boehringer Ingelheim outside the submitted work. Dr. Lewington reports grants from MRC-UK during the conduct of the study and a grant from the CDC Foundation, with support from Amgen, outside the submitted work. Dr. Emberson reports grants from the MRC during the conduct of the study and grants from Boehringer Ingelheim outside the submitted work. Authors not named here have disclosed no conflicts of interest. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M18-3502.
Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that her spouse has stock options/holdings with Targeted Diagnostics and Therapeutics. Darren B. Taichman, MD, PhD, Executive Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Catharine B. Stack, PhD, MS, Deputy Editor, Statistics, reports that she has stock holdings in Pfizer, Johnson & Johnson, and Colgate-Palmolive. Christina C. Wee, MD, MPH, Deputy Editor, reports employment with Beth Israel Deaconess Medical Center. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Yu-Xiao Yang, MD, MSCE, Deputy Editor, reports that he has no financial relationships or interest to disclose.
Reproducible Research Statement: Study protocol and data set: Not applicable. Statistical code: Available from Dr. Emberson (e-mail, [email protected]).
Corresponding Authors: Jonathan R. Emberson, PhD, MRC Population Health Research Unit, Nuffield Department of Population Health, Richard Doll Building, Old Road Campus, Roosevelt Drive, Oxford OX3 7LF, United Kingdom; e-mail, [email protected], and Jesus Alegre-Díaz, MD, Facultad de Medicina UNAM, Avenida Universidad 3000, Cd. Universitaria, 04510 Coyoacan, Mexico City, Mexico; e-mail, [email protected].
Current Author Addresses: Ms. Gnatiuc and Drs. Clarke, Collins, and Peto: Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, Richard Doll Building, Old Road Campus, Roosevelt Drive, Oxford OX3 7LF, United Kingdom. Ms. Wade and Drs. Herrington, Hill, Lewington, and Emberson: MRC Population Health Research Unit, Nuffield Department of Population Health, Richard Doll Building, Old Road Campus, Roosevelt Drive, Oxford OX3 7LF, United Kingdom.
Drs. Alegre-Díaz, Tapia-Conyer, and Kuri-Morales; Mr. Ramirez-Reyes; Mr. Garcilazo-Ávila; Mr. Gonzáles-Carballo; and Ms. Solano-Sanchez: Facultad de Medicina UNAM, Avenida Universidad 3000, Cd. Universitaria, 04510 Coyoacan, Mexico City, Mexico.
Dr. Chiquete: Salvador Zubirán National Institute of Medical Sciences and Nutrition, Vasco de Quiroga 15, Belisario Domínguez Secc 16, 14080 Mexico City, Mexico.
Author Contributions: Conception and design: L. Gnatiuc, J. Alegre-Díaz, R. Tapia-Conyer, R. Clarke, R. Peto, J.R. Emberson, P. Kuri-Morales.
Analysis and interpretation of the data: L. Gnatiuc, R. Wade, R. Clarke, R. Peto, J.R. Emberson.
Drafting of the article: L. Gnatiuc, J.R. Emberson.
Critical revision for important intellectual content: L. Gnatiuc, J. Alegre-Díaz, R. Wade, R. Ramirez-Reyes, R. Tapia-Conyer, A. Garcilazo-Ávila, E. Chiquete, C. Gonzáles-Carballo, M. Solano-Sanchez, R. Clarke, R. Collins, W.G. Herrington, M. Hill, S. Lewington, R. Peto, J.R. Emberson, P. Kuri-Morales.
Final approval of the article: L. Gnatiuc, J. Alegre-Díaz, R. Wade, R. Ramirez-Reyes, R. Tapia-Conyer, A. Garcilazo-Ávila, E. Chiquete, C. Gonzáles-Carballo, M. Solano-Sanchez, R. Clarke, R. Collins, W.G. Herrington, M. Hill, S. Lewington, R. Peto, J.R. Emberson, P. Kuri-Morales.
Statistical expertise: R. Wade, R. Peto, J.R. Emberson.
Obtaining of funding: J. Alegre-Díaz, R. Tapia-Conyer, R. Collins, R. Peto, J.R. Emberson, P. Kuri-Morales.
Administrative, technical, or logistic support: R. Ramirez-Reyes, M. Solano-Sanchez, M. Hill.
Collection and assembly of data: J. Alegre-Díaz, R. Ramirez-Reyes, R. Tapia-Conyer, W.G. Herrington, M. Hill, J.R. Emberson, P. Kuri-Morales.
This article was published at Annals.org on 13 August 2019.
* Ms. Gnatiuc and Dr. Alegre-Díaz share first authorship.
† Drs. Emberson and Kuri-Morales share last authorship.

Metrics & Citations

Metrics

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format





Download article citation data for:
Louisa Gnatiuc, Jesus Alegre-Díaz, Rachel Wade, et al. General and Abdominal Adiposity and Mortality in Mexico City: A Prospective Study of 150 000 Adults. Ann Intern Med.2019;171:397-405. [Epub 13 August 2019]. doi:10.7326/M18-3502

View More

Login Options:
Purchase

You will be redirected to acponline.org to sign-in to Annals to complete your purchase.

Access to EPUBs and PDFs for FREE Annals content requires users to be registered and logged in. A subscription is not required. You can create a free account below or from the following link. You will be redirected to acponline.org to create an account that will provide access to Annals. If you are accessing the Free Annals content via your institution's access, registration is not required.

Create your Free Account

You will be redirected to acponline.org to create an account that will provide access to Annals.

View options

PDF/EPUB

View PDF/EPUB

Related in ACP Journals

Full Text

View Full Text

Figures

Tables

Media

Share

Share

Copy the content Link

Share on social media